Publication:
Características clínicas y patológicas del melanoma maligno en cartagena

dc.contributor.authorHerrera Arrieta, Jairospa
dc.contributor.authorJuan Guardela, Emiliospa
dc.contributor.authorPaternina Caicedo, Ángelspa
dc.contributor.authorAlvis Zakzuk, Nelsonspa
dc.date.accessioned2014-01-15 00:00:00
dc.date.available2014-01-15 00:00:00
dc.date.issued2014-01-15
dc.format.mimetypeapplication/pdfspa
dc.identifier.doi10.32997/rcb-2014-2889
dc.identifier.eissn2389-7252
dc.identifier.issn2215-7840
dc.identifier.urihttps://hdl.handle.net/11227/13112
dc.identifier.urlhttps://doi.org/10.32997/rcb-2014-2889
dc.language.isospaspa
dc.publisherUniversidad de Cartagenaspa
dc.relation.bitstreamhttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/2889/2432
dc.relation.citationeditionNúm. 1 , Año 2014spa
dc.relation.citationendpage70
dc.relation.citationissue1spa
dc.relation.citationstartpage66
dc.relation.citationvolume5spa
dc.relation.ispartofjournalRevista Ciencias Biomédicasspa
dc.relation.referencesGLOBOCAN: Estimate cancer incidence, mortality and prevalence wordwide in 2012 [Internet]. Lyons: International Agency for the Reseach Cancer; 2014. GLOBOCAN Hojas informativas de población; 2014 enero 1 [cited 2014 Enero 14]; Available from: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx.spa
dc.relation.referencesErdmann F, Lortet-Tieulent J, Schûz J, Greinert R. International trends in the incidence of malignant melanoma 1953-2008-are recent generations at higher or lower risk? Int J Cancer. 2013; 132(2):385-400.spa
dc.relation.referencesRigel DS. Epidemiology of melanoma. Semin Cutan Med Surg. 2010;29(4):204-209.spa
dc.relation.referencesSiegel R, Naishadham M, Jemal A. Cancer statistics. CA Cancer J Clin. 2010;60(5):277-300.spa
dc.relation.referencesPailoor J, Mun KS, Leow M. Cutaneous malignant melanoma: clinical and histopathological review of cases in a Malaysian tertiary referral centre. Malayos J Pathol. 2012;34(2): 97-101.spa
dc.relation.referencesGiblin AV, Thomas JM. Incidence, mortality and survival in cutaneous melanoma. J Plast Surg Reconstr Aesthet. 2007;60(1):32-40.spa
dc.relation.referencesAcosta AE, Fierro E, Velásquezes VE, Rueda X. Melanoma: patogénesis, clínica e histopatología. Rev. Asoc. Col. Dermatol. 2009;17(2):87-108.spa
dc.relation.referencesKennedy C,Bajdik CD. Descriptive epidemiology of skin cancer on Aruba: 1980-1995. Int J Dermatol. 2001; 40(3):169-174.spa
dc.relation.referencesBreslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg.1970;172(5):902-928.spa
dc.relation.referencesWeedon D. Weedon Skin pathology. Sydney:Churchill-Livingstone; 2002.spa
dc.relation.referencesLozano R, Naghavi M, Capataz K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095-2128.spa
dc.relation.referencesTuong W, Cheng LS, Armstrong AW. Melanoma: epidemiology, diagnosis, treatment, and outcomes. Dermatol Clin. 2012;30(1):113-124.spa
dc.relation.referencesSánchez G, Nova J, de la Hoz C, Castañeda C. Incidencia de cáncer de piel en Colombia, años 2003- 2007. Piel. 2011. 26(4):171-177.spa
dc.relation.referencesChristenson LJ, Borrwman TA, Vachon CM, Megha M, Tollefson MD, Clark C, et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA. 2005;294(6):681-690.spa
dc.relation.referencesKaragas MR, Greenberg ER, Spencer SK, Stukel TA, Mott LA. Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. Int J Cancer. 1999;81:555-559.spa
dc.relation.referencesGutiérrez C, Alarcón E, Valle R, Calderón G. Epidemiología del melanoma maligno en el Instituto Nacional de Enfermedades Neoplásicas, Perú, 2000-2004. Folia dermatol Perú. 2007;18(1):23-27.spa
dc.relation.referencesSan Martin A, Qininir SL, Villaseca HM, Bustos ML. Características clínico-patológicas del melanoma maligno en pacientes del Hospital Hernán Henríquez Aravena de Temuco. Rev. ANACEM. 2008;II(1):36-39.spa
dc.relation.referencesRosas S, Baca T, Muñoz D, Muñoz F, Muñoz G. Estudio clínico, epidemiológico e histopatológico de melanoma maligno. Serie de 31 casos. CIMEL. 2003; 8(1):24-28.spa
dc.rightsRevista Ciencias Biomédicas - 2020spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.sourcehttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/2889spa
dc.subjectMelanomaspa
dc.subjectNeoplasias cutáneasspa
dc.subjectServicio de oncología en hospital.spa
dc.titleCaracterísticas clínicas y patológicas del melanoma maligno en cartagenaspa
dc.title.translatedCaracterísticas clínicas y patológicas del melanoma maligno en cartagenaeng
dc.typeArtículo de revistaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.localJournal articleeng
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dspace.entity.typePublication

Files

Datos de Contacto

Imagen Escudo Universidad de Cartagena

 

 

 

Línea de Atención

Línea Anticorrupción

Síguenos en: